Multiplikator Forward P/S: Integra LifeSciences Holdings Corporation (IART)
With premium pricing power in neurosurgery, Integra LifeSciences (IART) has temporarily faced regulatory constraints. The projected P/S multiple, where the metric level is 0.00, helps assess the chances of a price recovery. Stable cash flow is supported by consistent demand for consumables, while growth potential is based on the restart of capacities and strategic acquisitions.
Ringkesan rincian data analitis Integra LifeSciences Inc. (IART)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Integra LifeSciences|IART - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Integra LifeSciences|IART - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Integra LifeSciences Inc.|IART - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Integra LifeSciences|Rasio cepet integralife.com
- rincian asil keuangan lan kelipatan valuasi:
IART - Penghasilan resik perusahaan|Bathi sing dikarepake Integra LifeSciences|IART - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Integra|IART - Pangali PEG|Pangali EV/EBITDA Integra LifeSciences Inc.|IART - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Integra LifeSciences|IART - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan integralife.com|IART - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Integra LifeSciences
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:IART (Integra LifeSciences Holdings Corporation)
When screening for issuer reliability, it is critical to evaluate market value relative to expected sales. Forward P/S is calculated as the ratio of current market capitalization to projected revenue, eliminating the volatility of short-term quotes. For Integra LifeSciences (IART), this ratio reflects the market rate for synergies derived from the acquisition of biomaterial developers and neurosurgery partnerships. The trend of the forward P/S indicator on the GURU.Markets platform allows for the differentiation of real business growth from speculative liquidity inflows.
Karo sapa Integra LifeSciences saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|ESTA - Rasio rega marang prakiraan pendapatan|BBNX: Rasio rega marang prakiraan pendapatan|IRMD (Iradimed) - Multiplikator forward rega marang pendapatan|Embecta Health - Rega forward marang dodolan|TNDM (Tandem Diabetes Care) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep axogeninc.com AXGN|Rasio rega marang prakiraan pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prakiraan rega marang pendapatan|Bioventus Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|XTNT - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|Kapitalisasi marang prakiraan pendapatan MODD (Modular Med)|Multiplikator forward rega marang pendapatan MYO (Myomo, Inc)|Rasio rega marang pendapatan sing dikarepake COCH|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|envveno.com (NVNO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SINTX Technologies - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Tenon Medical Inc. (TNON)|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Autonomix Medical - Rega forward marang dodolan|IVF (INVO Fertility Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S bonebiologics.com|Multiplikator forward rega marang pendapatan AXNX (Axonics)|BIOL (BIOLASE Inc.) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|Paragon 28 Inc. - Rasio rega marang prakiraan pendapatan|INVO Bio - Multiplikator Forward P/S
